Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics in Radical Cystectomy
NCT06190197Phase 1Recruiting
- Sponsor
- University of Minnesota
- Start
- May 2024
- Primary completion
- Oct 2027
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nitrofurantoin in urinary tract infection (UTI) (2 arms), sponsored by University of Minnesota. Primary endpoints: Rate of postoperative urinary tract infections at 90 days and Difference in risk of postoperative urinary tract infections at 90 days. Started May 2024; status: recruiting.
02
Drugs
nitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06190197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06190197.